AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vaccine candidates clear review; phase III results expected within month.(AIDS)(Brief Article)
2002 MAY 29 - (NewsRx.com & NewsRx.net) -- The independent committee that oversees the only final-stage clinical trials of AIDS vaccine candidates has once again indicated that the vaccine candidates appear safe and that the trials are being conducted appropriately, VaxGen, Inc., (VXGN) announced.
In its seventh review of the phase III trials of VaxGen's preventive AIDS vaccine candidates, the independent data and safety monitoring board (DSMB) found that the vaccine candidates continue to exhibit a strong safety profile. Since human clinical trials first began, more than 32,000 injections have been administered.
Two formulations are being tested in separate trials - AIDSVAX B/B in North America and Europe and AIDSVAX B/E in Thailand - involving a total of nearly 8000 volunteers.
The final analysis of the trial in North America and Europe, to evaluate both the safety and effectiveness of AIDSVAX B/B, is planned for the first quarter of 2003. The final analysis of the Thai trial is planned for the fourth quarter of 2003.
"Safety is a top priority in ...
- VaxGen Raises $5 Million Through Sale of Common Stock; Proceeds to Fund...
- Press release article from: PR Newswire May 20, 2003 700+ words
VaxGen, Inc. announced today...160 newly issued shares of VaxGen's common stock to a single...fund the development of vaccine candidates for anthrax and smallpox...offering may be obtained from VaxGen, 1000 Marina Blvd., Brisbane...
- VaxGen Raises $7 Million Through Sale of Common Stock; Proceeds to Fund...
- Press release article from: PR Newswire June 9, 2003 700+ words
...weighted average price of VaxGen's common stock during the...19991112/VAXGENLOGO ) VaxGen intends to use the net proceeds...to fund the development of vaccine candidates for anthrax and smallpox and...Francisco acted as adviser to VaxGen. A registration statement...
- VaxGen Biopharmaceutical Manufacturing Joint Venture Appoints Senior Officers...
- Press release article from: PR Newswire March 27, 2002 700+ words
...manufacture of VaxGen's AIDS vaccine candidates. (Photo: http...products, including VaxGen's AIDS vaccine candidates, should they...including its vaccine candidates, should they be licensed. VaxGen expects to announce...
- VaxGen Awarded NIAID/NIH Grant to Identify Novel Antigens for Possible New HIV...
- Press release article from: PR Newswire June 10, 2003 700+ words
...antigens to create vaccine candidates for potential...the SBIR grant, VaxGen collected HIV...products, including VaxGen's vaccine candidates, should they...HIV to create vaccine candidates; and VaxGen's ability to...
- VaxGen Selected by U.S. Government to Develop New Anthrax Vaccine.
- Press release article from: PR Newswire October 3, 2002 700+ words
...to10 million doses per year of VaxGen's AIDS vaccine candidates, if they are licensed. Under...biopharmaceutical products, including VaxGen's vaccine candidates, should they be licensed. VaxGen is located in Brisbane, Calif...
- VaxGen to Present at Friedland Capital's Security, Protection & Defense...
- Press release article from: PR Newswire November 14, 2002 700+ words
...the only company with AIDS vaccine candidates in Phase III clinical trials. VaxGen expects to announce primary...biopharmaceutical products, including VaxGen's vaccine candidates, should they be licensed. VaxGen is located in Brisbane, Calif...
- VaxGen Opens Biopharmaceutical Manufacturing Facility in South San Francisco.
- Press release article from: PR Newswire June 23, 2003 700+ words
...designed to manufacture VaxGen's anthrax vaccine and AIDS vaccine candidates, as well as other biopharmaceuticals...products, including VaxGen's vaccine candidates, should they be licensed...at: http://www.vaxgen.com/ Note: This...
- VaxGen Congratulates HIV Prime-Boost Vaccine Study Collaborators and Clarifies...
- Newspaper article from: U.S. Newswire September 25, 2009 700+ words
...and sell its HIV vaccine candidates, including the AIDSVAX B/E vaccine. VaxGen retains an option to...or equivalent). VaxGen has no rights or obligations...manufacture or develop the vaccine candidates unless and until it exercises this option. If VaxGen exercises its option...
